|
|
Volumn 9, Issue 3, 2010, Pages 182-
|
|
Trial watch: SGLT2 inhibitor shows promise in type 2 diabetes
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
LX 4211;
PLACEBO;
SODIUM GLUCOSE COTRANSPORTER 2;
UNCLASSIFIED DRUG;
ANTIDIABETIC ACTIVITY;
DIABETIC DIET;
GLYCEMIC CONTROL;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SHORT SURVEY;
TREATMENT DURATION;
BLOOD PRESSURE;
BODY WEIGHT;
CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS, TYPE 2;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DELIVERY SYSTEMS;
DRUGS, INVESTIGATIONAL;
HUMANS;
HYPOGLYCEMIC AGENTS;
SODIUM-GLUCOSE TRANSPORTER 2;
TRIGLYCERIDES;
|
|
EID: 84872123171
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3127 Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|